Green John L. 4
4 · Cogent Biosciences, Inc. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
Green John L.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-25$4.94/sh+225,000$1,112,220→ 225,000 totalExercise: $7.60Exp: 2032-01-25→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.